RECRUITINGOBSERVATIONAL
Advanced Glycation Products and Vascular Complications in Type 1 Diabetes
Advanced Glycation Products and the Incidence of Vascular Complications in Type 1 Diabetes: DIABAGE Study After More Than 5 Years
About This Trial
DIABAGE (Diabetes Advanced Glycation End products) study was conducted between 2015 and 2017. It included 196 type 1 diabetic patients with more than 10 years of diabetes. It revealed a significant association between the occurrence of vascular complications and tissular Advanced Glycation End products (AGEs) as well as with some circulating AGEs. This protocol is a continuation of that initial research.
Who May Be Eligible (Plain English)
Who May Qualify:
- Inclusion in initial DIABAGE study.
- Follow-up at Reims hospital.
Who Should NOT Join This Trial:
\- Refusal to participate.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Inclusion in initial DIABAGE study.
* Follow-up at Reims hospital.
Exclusion Criteria:
\- Refusal to participate.
Locations (1)
Chu Reims
Reims, France